Epoetin beta - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
NEORECORMON epoetin beta (rch) 10 000 IU/0.6 mL injection syringe AUST R: 104267 Active ingredients: Epoetin beta Dosage form: Injection Sponsor: Roche Products Pty Ltd Phone: 1800 233 950	Deletion from market: 09 Nov 2025	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Commercial Changes / Commercial viability Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
NEORECORMON epoetin beta (rch) 2000 IU/0.3 mL injection syringe AUST R: 104262 Active ingredients: Epoetin beta Dosage form: Injection Sponsor: Roche Products Pty Ltd Phone: 1800 233 950	Deletion from market: 09 Nov 2025	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Transport / Logistic issues / Storage capacity issues Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
NEORECORMON epoetin beta (rch) 3000 IU/0.3 mL injection syringe AUST R: 104263 Active ingredients: Epoetin beta Dosage form: Injection Sponsor: Roche Products Pty Ltd Phone: 1800 233 950	Deletion from market: 23 Nov 2025	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Transport / Logistic issues / Storage capacity issues Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
NEORECORMON epoetin beta (rch) 4000 IU/0.3 mL injection syringe AUST R: 104264 Active ingredients: Epoetin beta Dosage form: Injection Sponsor: Roche Products Pty Ltd Phone: 1800 233 950	Deletion from market: 21 Sep 2025	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Transport / Logistic issues / Storage capacity issues Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
NEORECORMON epoetin beta (rch) 5000 IU/0.3 mL injection syringe AUST R: 104265 Active ingredients: Epoetin beta Dosage form: Injection Sponsor: Roche Products Pty Ltd Phone: 1800 233 950	Deletion from market: 09 Oct 2025	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Transport / Logistic issues / Storage capacity issues Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.
NEORECORMON epoetin beta (rch) 6000 IU/0.3 mL injection syringe AUST R: 104266 Active ingredients: Epoetin beta Dosage form: Injection Sponsor: Roche Products Pty Ltd Phone: 1800 233 950	Deletion from market: 16 Sep 2025	Shortage status: To be discontinued Availability: Reduction in supply until supply is exhausted Reason: Transport / Logistic issues / Storage capacity issues Management action: Patients are advised to consult their healthcare professional to discuss alternative treatment options.